Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00978406 · ClinicalTrials.gov registry record
National Cancer Institute Food Study
A clinical trial of Epidemiology and Nutritional Assessment, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- 83
- Enrollment target
- 1
- Study location
NCT00978406: Completed study of Epidemiology and Nutritional Assessment, sponsored by National Cancer Institute (NCI).
NCT00978406 is a study of Epidemiology and Nutritional Assessment that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 83 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00978406, a study of Epidemiology and Nutritional Assessment, has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- 83 participants
- Enrollment target
- 1
- Study location
Study Summary
Information about Americans food choices and opinions helps researchers and law makers to develop policies and programs to promote health. For this reason, it is important to be able to collect good quality information about how people think about food. This project will compare different ways of collecting information about food from adults.
Primary Outcome
Measured exact intake of foods will be compared to reported intake by the participant. Two different reporting systems will be compared with truth.
Conditions Studied
Study Locations (1)
Maryland
- Westat, Inc. - Rockville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 83 participants |
| Start Date | 2009-08-26 |
| Est. Completion | 2020-02-26 |
What the finished NCT00978406 record still lists
NCT00978406 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 83 participants, a relatively small participant target.
The record links to 5 conditions, with Epidemiology appearing as the primary indexed condition, and to 0 interventions.
NCT00978406 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT00978406 about?
NCT00978406 is a clinical study titled "National Cancer Institute Food Study". Information about Americans food choices and opinions helps researchers and law makers to develop policies and programs to promote health. For this reason, it is important to be able to collect good quality information about how people think about food. This project will compare different ways of co...
What is the current status of trial NCT00978406?
This trial is currently completed. The enrollment target is 83 participants. The study started on 2009-08-26. Estimated completion is 2020-02-26.
What conditions does trial NCT00978406 study?
This clinical trial studies the following conditions: Epidemiology, Nutritional Assessment, Diet Surveys, Validation Study, Methodologic Study.
Who is sponsoring clinical trial NCT00978406?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00978406 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Epidemiology
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02974647 · 83 participants · Phase 2
Study of Ruxolitinib in Relapsed or Refractory T or NK Cell Lymphoma
- NCT03919292 · 83 participants · Phase 1
Neratinib + Valproate in Advanced Solid Tumors, w/Expansion Cohort in Ras-Mutated Ca
- NCT04626674 · 83 participants · Phase 1
A Gene Transfer Therapy Study to Evaluate the Safety of and Expression From Delandistrogene Moxeparvovec (SRP-9001) in Participants With Duchenne Muscular Dystrophy (DMD)
- NCT05277168 · 83 participants · Phase 1
A Trial TO Evaluate THE Safety, Tolerability, Pharmacokinetics, AND Efficacy OF Shr-a1904 IN Subjects With Advanced Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI